Index by Author

July 1999; 22 (7)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Adler, A I

    • Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care July 1999 22:1029-1035; doi:10.2337/diacare.22.7.1029

  2. Ahroni, J H

    • Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care July 1999 22:1029-1035; doi:10.2337/diacare.22.7.1029
    • A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care July 1999 22:1036-1042; doi:10.2337/diacare.22.7.1036

  3. Alvarsson, M

    • Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men. Diabetes Care July 1999 22:1043-1047; doi:10.2337/diacare.22.7.1043

B

  1. Bache, I

    • Previous maternal abortion, longer gestation, and younger maternal age decrease the risk of type 1 diabetes among male offspring. Diabetes Care July 1999 22:1063-1065; doi:10.2337/diacare.22.7.1063

  2. Bajaj, M

    • Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care July 1999 22:1022-1028; doi:10.2337/diacare.22.7.1022

  3. Bakst, A W

    • Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care July 1999 22:1116-1124; doi:10.2337/diacare.22.7.1116

  4. Bean, J A

    • Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study. Diabetes Care July 1999 22:1092-1096; doi:10.2337/diacare.22.7.1092

  5. Becker, D

    • Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study. Diabetes Care July 1999 22:1084-1091; doi:10.2337/diacare.22.7.1084

  6. Berden, J H

    • Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy. Diabetes Care July 1999 22:1048-1052; doi:10.2337/diacare.22.7.1048

  7. Berg, T J

    • Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care July 1999 22:1186-1190; doi:10.2337/diacare.22.7.1186

  8. Bierhaus, A

    • alpha-Tocopherol induces leptin expression in healthy individuals and in vitro. Diabetes Care July 1999 22:1227-1228; doi:10.2337/diacare.22.7.1227a

  9. Bloomgarden, Z T

    • The European Association for the Study of Diabetes Annual Meeting, 1998. Treatment of type 2 diabetes and the pathogenesis of complications. Diabetes Care July 1999 22:1209-1215

  10. Blum, W F

    • Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care July 1999 22:1097-1104; doi:10.2337/diacare.22.7.1097

  11. Bock, T

    • Previous maternal abortion, longer gestation, and younger maternal age decrease the risk of type 1 diabetes among male offspring. Diabetes Care July 1999 22:1063-1065; doi:10.2337/diacare.22.7.1063

  12. Bouter, L M

    • Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care July 1999 22:1097-1104; doi:10.2337/diacare.22.7.1097

  13. Boyko, E J

    • Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care July 1999 22:1029-1035; doi:10.2337/diacare.22.7.1029
    • A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care July 1999 22:1036-1042; doi:10.2337/diacare.22.7.1036

  14. Branch, D R

    • High-dose vitamin C supplementation increases plasma glucose. Diabetes Care July 1999 22:1218-1219; doi:10.2337/diacare.22.7.1218

  15. Brown, J B

    • Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care July 1999 22:1116-1124; doi:10.2337/diacare.22.7.1116

  16. Brunzell, J D

    • Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes. Diabetes Care July 1999 22:1165-1170; doi:10.2337/diacare.22.7.1165

  17. Buschard, K

    • Previous maternal abortion, longer gestation, and younger maternal age decrease the risk of type 1 diabetes among male offspring. Diabetes Care July 1999 22:1063-1065; doi:10.2337/diacare.22.7.1063

C

  1. Carlsson, S

    • Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men. Diabetes Care July 1999 22:1043-1047; doi:10.2337/diacare.22.7.1043

  2. Catino, M

    • Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Diabetes Care July 1999 22:1158-1164; doi:10.2337/diacare.22.7.1158

  3. Chambless, L E

    • Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care July 1999 22:1077-1083; doi:10.2337/diacare.22.7.1077

  4. Chatterjee, S

    • 2-year prospective audit of the effect of the introduction of insulin lispro in patients with specific clinical indications. Diabetes Care July 1999 22:1226-1227; doi:10.2337/diacare.22.7.1226

  5. Chen, Y T

    • Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia. Diabetes Care July 1999 22:1224-1225; doi:10.2337/diacare.22.7.1224

  6. Cheng, A Y

    • Cultural adaptation of the diabetes quality-of-life measure for Chinese patients. Diabetes Care July 1999 22:1216-1217; doi:10.2337/diacare.22.7.1216

  7. Chiarelli, F

    • Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Diabetes Care July 1999 22:1158-1164; doi:10.2337/diacare.22.7.1158

  8. Cleary, P A

    • Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes. Diabetes Care July 1999 22:1165-1170; doi:10.2337/diacare.22.7.1165

  9. Collier, G

    • Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study. Diabetes Care July 1999 22:1092-1096; doi:10.2337/diacare.22.7.1092

  10. Cooper, L S

    • Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care July 1999 22:1077-1083; doi:10.2337/diacare.22.7.1077

  11. Cox, D J

    • Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care July 1999 22:1022-1028; doi:10.2337/diacare.22.7.1022

  12. Crowne, E C

    • Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes. Diabetes Care July 1999 22:1144-1150; doi:10.2337/diacare.22.7.1144

D

  1. Davidson, J

    • Revised standards for the treatment of type 2 diabetes in Texas. Diabetes Care July 1999 22:1219-1220; doi:10.2337/diacare.22.7.1219

  2. Davignon, D R

    • A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care July 1999 22:1036-1042; doi:10.2337/diacare.22.7.1036

  3. De Courten, M

    • Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study. Diabetes Care July 1999 22:1092-1096; doi:10.2337/diacare.22.7.1092

  4. Deb, P

    • Work disability and diabetes. Diabetes Care July 1999 22:1105-1109; doi:10.2337/diacare.22.7.1105

  5. Dekker, J M

    • Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care July 1999 22:1097-1104; doi:10.2337/diacare.22.7.1097

  6. Donahue, R D

    • Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study. Diabetes Care July 1999 22:1092-1096; doi:10.2337/diacare.22.7.1092

  7. Donahue, R P

    • Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study. Diabetes Care July 1999 22:1092-1096; doi:10.2337/diacare.22.7.1092

  8. Dunger, D B

    • Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes. Diabetes Care July 1999 22:1144-1150; doi:10.2337/diacare.22.7.1144

  9. de Martino, M

    • Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Diabetes Care July 1999 22:1158-1164; doi:10.2337/diacare.22.7.1158

E

  1. Efendic, S

    • Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men. Diabetes Care July 1999 22:1043-1047; doi:10.2337/diacare.22.7.1043

  2. Elving, L D

    • Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy. Diabetes Care July 1999 22:1048-1052; doi:10.2337/diacare.22.7.1048

  3. England, B G

    • Is pregnancy in diabetic women associated with folate deficiency? Diabetes Care July 1999 22:1017-1021; doi:10.2337/diacare.22.7.1017

  4. Erbey, J R

    • Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study. Diabetes Care July 1999 22:1084-1091; doi:10.2337/diacare.22.7.1084

F

  1. Faber, J

    • Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care July 1999 22:1186-1190; doi:10.2337/diacare.22.7.1186

  2. Folsom, A R

    • Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care July 1999 22:1077-1083; doi:10.2337/diacare.22.7.1077

  3. Forsberg, R C

    • A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care July 1999 22:1036-1042; doi:10.2337/diacare.22.7.1036

  4. Fujiwara, K

    • Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes. Diabetes Care July 1999 22:1221-1224; doi:10.2337/diacare.22.7.1221

  5. Fukui, M

    • Clinical features of elderly patients with type 2 diabetes. Diabetes Care July 1999 22:1225-1226; doi:10.2337/diacare.22.7.1225

G

  1. Gallen, I W

    • 2-year prospective audit of the effect of the introduction of insulin lispro in patients with specific clinical indications. Diabetes Care July 1999 22:1226-1227; doi:10.2337/diacare.22.7.1226

  2. Garcia-Ingelmo, T

    • Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care July 1999 22:1053-1058; doi:10.2337/diacare.22.7.1053

  3. Gentile, S

    • Aminotransferase activity and acarbose treatment in patients with type 2 diabetes. Diabetes Care July 1999 22:1217-1218; doi:10.2337/diacare.22.7.1217

  4. Glauber, H S

    • Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care July 1999 22:1116-1124; doi:10.2337/diacare.22.7.1116

  5. Glick, H A

    • Determining an episode of care using claims data. Diabetic foot ulcer. Diabetes Care July 1999 22:1110-1115; doi:10.2337/diacare.22.7.1110

  6. Goldberg, R B

    • Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study. Diabetes Care July 1999 22:1092-1096; doi:10.2337/diacare.22.7.1092

  7. Gonzalez, A

    • Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care July 1999 22:1053-1058; doi:10.2337/diacare.22.7.1053

  8. Grande, C

    • Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care July 1999 22:1053-1058; doi:10.2337/diacare.22.7.1053

  9. Grill, V

    • Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men. Diabetes Care July 1999 22:1043-1047; doi:10.2337/diacare.22.7.1043

  10. Guarino, G

    • Aminotransferase activity and acarbose treatment in patients with type 2 diabetes. Diabetes Care July 1999 22:1217-1218; doi:10.2337/diacare.22.7.1217

H

  1. Hanley, A J

    • Cultural adaptation of the diabetes quality-of-life measure for Chinese patients. Diabetes Care July 1999 22:1216-1217; doi:10.2337/diacare.22.7.1216

  2. Hanssen, K F

    • Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care July 1999 22:1186-1190; doi:10.2337/diacare.22.7.1186

  3. Harrower, A

    • Effect of fiber intake and meal pattern on gastrointestinal symptoms with acarbose. Diabetes Care July 1999 22:1227; doi:10.2337/diacare.22.7.1227b

  4. Harrower, A D

    • Effect of fiber intake and meal pattern on gastrointestinal symptoms with acarbose. Diabetes Care July 1999 22:1227; doi:10.2337/diacare.22.7.1227b

  5. Havel, P J

    • Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes. Diabetes Care July 1999 22:1144-1150; doi:10.2337/diacare.22.7.1144

  6. Hayakawa, M

    • Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes. Diabetes Care July 1999 22:1176-1180; doi:10.2337/diacare.22.7.1176

  7. Hayakawa, T

    • Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level. Diabetes Care July 1999 22:1220-1221; doi:10.2337/diacare.22.7.1220a

  8. Heine, R J

    • Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care July 1999 22:1097-1104; doi:10.2337/diacare.22.7.1097

  9. Heinze, E

    • Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care July 1999 22:1151-1157; doi:10.2337/diacare.22.7.1151

  10. Heiss, G

    • Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care July 1999 22:1077-1083; doi:10.2337/diacare.22.7.1077

  11. Herman, W H

    • Is pregnancy in diabetic women associated with folate deficiency? Diabetes Care July 1999 22:1017-1021; doi:10.2337/diacare.22.7.1017

  12. Herranz, L

    • Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care July 1999 22:1053-1058; doi:10.2337/diacare.22.7.1053

  13. Hildebrandt, P

    • Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care July 1999 22:1186-1190; doi:10.2337/diacare.22.7.1186

  14. Hirao, K

    • Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke. Diabetes Care July 1999 22:1191-1195; doi:10.2337/diacare.22.7.1191

  15. Hokanson, J E

    • Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes. Diabetes Care July 1999 22:1165-1170; doi:10.2337/diacare.22.7.1165

  16. Holl, R W

    • Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care July 1999 22:1151-1157; doi:10.2337/diacare.22.7.1151

  17. Holst, J J

    • Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Diabetes Care July 1999 22:1137-1143; doi:10.2337/diacare.22.7.1137

  18. Howard, G

    • Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care July 1999 22:1077-1083; doi:10.2337/diacare.22.7.1077

  19. Hozumi, T

    • Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes. Diabetes Care July 1999 22:1176-1180; doi:10.2337/diacare.22.7.1176

  20. Hsiao, P J

    • Increased urinary atrial natriuretic peptide-like immunoreactivity excretion but decreased plasma atrial natriuretic peptide concentration in patients with hyperosmolar-hyperglycemic nonketotic syndrome. Diabetes Care July 1999 22:1181-1185; doi:10.2337/diacare.22.7.1181

I

  1. Ikeda, Y

    • Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes. Diabetes Care July 1999 22:1176-1180; doi:10.2337/diacare.22.7.1176

  2. Impivaara, O

    • Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care July 1999 22:1196-1200; doi:10.2337/diacare.22.7.1196

  3. Iqbal, S

    • Is pregnancy in diabetic women associated with folate deficiency? Diabetes Care July 1999 22:1017-1021; doi:10.2337/diacare.22.7.1017

  4. Isermann, B

    • alpha-Tocopherol induces leptin expression in healthy individuals and in vitro. Diabetes Care July 1999 22:1227-1228; doi:10.2337/diacare.22.7.1227a

  5. Ishibashi, H

    • Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care July 1999 22:1071-1076; doi:10.2337/diacare.22.7.1071

  6. Ishida, Y

    • Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes. Diabetes Care July 1999 22:1176-1180; doi:10.2337/diacare.22.7.1176

  7. Itoh, M

    • Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes. Diabetes Care July 1999 22:1221-1224; doi:10.2337/diacare.22.7.1221

  8. Itoh, Y

    • Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes. Diabetes Care July 1999 22:1221-1224; doi:10.2337/diacare.22.7.1221

J

  1. Jack, H

    • Effect of fiber intake and meal pattern on gastrointestinal symptoms with acarbose. Diabetes Care July 1999 22:1227; doi:10.2337/diacare.22.7.1227b

  2. Jackson, R

    • Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients. Diabetes Care July 1999 22:1171-1175; doi:10.2337/diacare.22.7.1171

  3. Jacobson, A M

    • Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care July 1999 22:1022-1028; doi:10.2337/diacare.22.7.1022

  4. Jain, S K

    • Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients. Diabetes Care July 1999 22:1171-1175; doi:10.2337/diacare.22.7.1171

  5. Jañez, M

    • Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care July 1999 22:1053-1058; doi:10.2337/diacare.22.7.1053

  6. Juang, B L

    • Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia. Diabetes Care July 1999 22:1224-1225; doi:10.2337/diacare.22.7.1224

K

  1. Kakizawa, H

    • Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes. Diabetes Care July 1999 22:1221-1224; doi:10.2337/diacare.22.7.1221

  2. Kaplan, J S

    • Is pregnancy in diabetic women associated with folate deficiency? Diabetes Care July 1999 22:1017-1021; doi:10.2337/diacare.22.7.1017

  3. Karvonen, M

    • The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care July 1999 22:1066-1070; doi:10.2337/diacare.22.7.1066

  4. Kato, S

    • Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes. Diabetes Care July 1999 22:1221-1224; doi:10.2337/diacare.22.7.1221

  5. Kawakami, N

    • Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care July 1999 22:1071-1076; doi:10.2337/diacare.22.7.1071

  6. Kazumi, T

    • Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes. Diabetes Care July 1999 22:1176-1180; doi:10.2337/diacare.22.7.1176

  7. Kinsley, B T

    • Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care July 1999 22:1022-1028; doi:10.2337/diacare.22.7.1022

  8. Kishi, K

    • Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes. Diabetes Care July 1999 22:1176-1180; doi:10.2337/diacare.22.7.1176

  9. Knights, S

    • Birth weight of women with gestational diabetes. Diabetes Care July 1999 22:1059-1062; doi:10.2337/diacare.22.7.1059

  10. Kobayashi, T

    • Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes. Diabetes Care July 1999 22:1221-1224; doi:10.2337/diacare.22.7.1221

  11. Kondo, M

    • Clinical features of elderly patients with type 2 diabetes. Diabetes Care July 1999 22:1225-1226; doi:10.2337/diacare.22.7.1225

  12. Kostense, P J

    • Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care July 1999 22:1097-1104; doi:10.2337/diacare.22.7.1097

L

  1. Lee, W J

    • Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia. Diabetes Care July 1999 22:1224-1225; doi:10.2337/diacare.22.7.1224

  2. Lee, Y J

    • Increased urinary atrial natriuretic peptide-like immunoreactivity excretion but decreased plasma atrial natriuretic peptide concentration in patients with hyperosmolar-hyperglycemic nonketotic syndrome. Diabetes Care July 1999 22:1181-1185; doi:10.2337/diacare.22.7.1181

  3. Levine, S N

    • Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients. Diabetes Care July 1999 22:1171-1175; doi:10.2337/diacare.22.7.1171

  4. Levy, C J

    • Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care July 1999 22:1022-1028; doi:10.2337/diacare.22.7.1022

  5. Lim, G

    • Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients. Diabetes Care July 1999 22:1171-1175; doi:10.2337/diacare.22.7.1171

M

  1. Macdonald, I A

    • Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes. Diabetes Care July 1999 22:1144-1150; doi:10.2337/diacare.22.7.1144

  2. Madsbad, S

    • Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Diabetes Care July 1999 22:1137-1143; doi:10.2337/diacare.22.7.1137

  3. Makino, M

    • Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes. Diabetes Care July 1999 22:1221-1224; doi:10.2337/diacare.22.7.1221

  4. Marcovina, S M

    • Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes. Diabetes Care July 1999 22:1165-1170; doi:10.2337/diacare.22.7.1165

  5. Martin-Vaquero, P

    • Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care July 1999 22:1053-1058; doi:10.2337/diacare.22.7.1053

  6. Mason, P E

    • Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence. Diabetes Care July 1999 22:1206-1208; doi:10.2337/diacare.22.7.1206

  7. Mason, R P

    • Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence. Diabetes Care July 1999 22:1206-1208; doi:10.2337/diacare.22.7.1206

  8. Matsui, H

    • Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level. Diabetes Care July 1999 22:1220-1221; doi:10.2337/diacare.22.7.1220a

  9. Matsumoto, K

    • Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke. Diabetes Care July 1999 22:1191-1195; doi:10.2337/diacare.22.7.1191

  10. Matthews, D

    • Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes. Diabetes Care July 1999 22:1144-1150; doi:10.2337/diacare.22.7.1144

  11. Matyka, K A

    • Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes. Diabetes Care July 1999 22:1144-1150; doi:10.2337/diacare.22.7.1144

  12. Mayfield, J A

    • Work disability and diabetes. Diabetes Care July 1999 22:1105-1109; doi:10.2337/diacare.22.7.1105

  13. McVie, R

    • Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients. Diabetes Care July 1999 22:1171-1175; doi:10.2337/diacare.22.7.1171

  14. Mehlsen, J

    • Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care July 1999 22:1186-1190; doi:10.2337/diacare.22.7.1186

  15. Mehta, S S

    • Determining an episode of care using claims data. Diabetic foot ulcer. Diabetes Care July 1999 22:1110-1115; doi:10.2337/diacare.22.7.1110

  16. Mezzetti, A

    • Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Diabetes Care July 1999 22:1158-1164; doi:10.2337/diacare.22.7.1158

  17. Miyake, S

    • Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke. Diabetes Care July 1999 22:1191-1195; doi:10.2337/diacare.22.7.1191

  18. Miyazaki, A

    • Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke. Diabetes Care July 1999 22:1191-1195; doi:10.2337/diacare.22.7.1191

  19. Mizutani, T

    • Clinical features of elderly patients with type 2 diabetes. Diabetes Care July 1999 22:1225-1226; doi:10.2337/diacare.22.7.1225

  20. Mooy, J

    • Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care July 1999 22:1097-1104; doi:10.2337/diacare.22.7.1097

  21. Moses, J

    • Birth weight of women with gestational diabetes. Diabetes Care July 1999 22:1059-1062; doi:10.2337/diacare.22.7.1059

  22. Moses, R G

    • Birth weight of women with gestational diabetes. Diabetes Care July 1999 22:1059-1062; doi:10.2337/diacare.22.7.1059

N

  1. Nagasaka, A

    • Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes. Diabetes Care July 1999 22:1221-1224; doi:10.2337/diacare.22.7.1221

  2. Nagata, M

    • Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes. Diabetes Care July 1999 22:1221-1224; doi:10.2337/diacare.22.7.1221

  3. Nakamura, N

    • Clinical features of elderly patients with type 2 diabetes. Diabetes Care July 1999 22:1225-1226; doi:10.2337/diacare.22.7.1225

  4. Nawroth, P P

    • alpha-Tocopherol induces leptin expression in healthy individuals and in vitro. Diabetes Care July 1999 22:1227-1228; doi:10.2337/diacare.22.7.1227a

  5. Nichols, G A

    • Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care July 1999 22:1116-1124; doi:10.2337/diacare.22.7.1116

  6. Nijpels, G

    • Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care July 1999 22:1097-1104; doi:10.2337/diacare.22.7.1097

  7. Norman, A

    • Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men. Diabetes Care July 1999 22:1043-1047; doi:10.2337/diacare.22.7.1043

O

  1. Okumura, K

    • Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level. Diabetes Care July 1999 22:1220-1221; doi:10.2337/diacare.22.7.1220a

  2. Orchard, T J

    • Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study. Diabetes Care July 1999 22:1084-1091; doi:10.2337/diacare.22.7.1084
    • Glycemic control and CAD risk: a heretical thought. Diabetes Care July 1999 22:1220; doi:10.2337/diacare.22.7.1220b

  3. Ostenson, C G

    • Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men. Diabetes Care July 1999 22:1043-1047; doi:10.2337/diacare.22.7.1043

P

  1. Pallardo, F

    • Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care July 1999 22:1053-1058; doi:10.2337/diacare.22.7.1053

  2. Pavlovic, M

    • Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care July 1999 22:1151-1157; doi:10.2337/diacare.22.7.1151

  3. Persson, P G

    • Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men. Diabetes Care July 1999 22:1043-1047; doi:10.2337/diacare.22.7.1043

  4. Pitkäniemi, J

    • The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care July 1999 22:1066-1070; doi:10.2337/diacare.22.7.1066

  5. Prineas, R J

    • Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study. Diabetes Care July 1999 22:1092-1096; doi:10.2337/diacare.22.7.1092

  6. Purnell, J Q

    • Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes. Diabetes Care July 1999 22:1165-1170; doi:10.2337/diacare.22.7.1165

  7. Puukka, P

    • Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care July 1999 22:1196-1200; doi:10.2337/diacare.22.7.1196

Q

  1. Quigley, M

    • Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care July 1999 22:1022-1028; doi:10.2337/diacare.22.7.1022

R

  1. Rasmussen, M L

    • Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care July 1999 22:1077-1083; doi:10.2337/diacare.22.7.1077

  2. Ruige, J B

    • Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care July 1999 22:1097-1104; doi:10.2337/diacare.22.7.1097

  3. Rönnemaa, T

    • Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care July 1999 22:1196-1200; doi:10.2337/diacare.22.7.1196

S

  1. Sandler, L

    • 2-year prospective audit of the effect of the introduction of insulin lispro in patients with specific clinical indications. Diabetes Care July 1999 22:1226-1227; doi:10.2337/diacare.22.7.1226

  2. Sasso, F C

    • Aminotransferase activity and acarbose treatment in patients with type 2 diabetes. Diabetes Care July 1999 22:1217-1218; doi:10.2337/diacare.22.7.1217

  3. Schmidt, M I

    • Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care July 1999 22:1077-1083; doi:10.2337/diacare.22.7.1077

  4. Schneiderman, N

    • Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study. Diabetes Care July 1999 22:1092-1096; doi:10.2337/diacare.22.7.1092

  5. Schulman, K A

    • Determining an episode of care using claims data. Diabetic foot ulcer. Diabetes Care July 1999 22:1110-1115; doi:10.2337/diacare.22.7.1110

  6. Schwartz, R

    • What is the significance of macrosomia? Diabetes Care July 1999 22:1201-1205; doi:10.2337/diacare.22.7.1201

  7. Sheu, W H

    • Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia. Diabetes Care July 1999 22:1224-1225; doi:10.2337/diacare.22.7.1224

  8. Shimizu, H

    • Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care July 1999 22:1071-1076; doi:10.2337/diacare.22.7.1071

  9. Shin, S J

    • Increased urinary atrial natriuretic peptide-like immunoreactivity excretion but decreased plasma atrial natriuretic peptide concentration in patients with hyperosmolar-hyperglycemic nonketotic syndrome. Diabetes Care July 1999 22:1181-1185; doi:10.2337/diacare.22.7.1181

  10. Sibley, S D

    • Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes. Diabetes Care July 1999 22:1165-1170; doi:10.2337/diacare.22.7.1165

  11. Simonson, D C

    • Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care July 1999 22:1022-1028; doi:10.2337/diacare.22.7.1022

  12. Skyler, J S

    • Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study. Diabetes Care July 1999 22:1092-1096; doi:10.2337/diacare.22.7.1092

  13. Smith, D G

    • Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care July 1999 22:1029-1035; doi:10.2337/diacare.22.7.1029
    • A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care July 1999 22:1036-1042; doi:10.2337/diacare.22.7.1036

  14. Smits, P

    • Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy. Diabetes Care July 1999 22:1048-1052; doi:10.2337/diacare.22.7.1048

  15. Snorgaard, O

    • Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care July 1999 22:1186-1190; doi:10.2337/diacare.22.7.1186

  16. Steffes, M W

    • Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes. Diabetes Care July 1999 22:1165-1170; doi:10.2337/diacare.22.7.1165

  17. Stehouwer, C D

    • Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care July 1999 22:1097-1104; doi:10.2337/diacare.22.7.1097

  18. Stensel, V

    • A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care July 1999 22:1036-1042; doi:10.2337/diacare.22.7.1036

  19. Suzuki, S

    • Determining an episode of care using claims data. Diabetic foot ulcer. Diabetes Care July 1999 22:1110-1115; doi:10.2337/diacare.22.7.1110

  20. Svanström, L

    • Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men. Diabetes Care July 1999 22:1043-1047; doi:10.2337/diacare.22.7.1043

T

  1. Takatsuka, N

    • Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care July 1999 22:1071-1076; doi:10.2337/diacare.22.7.1071

  2. Teramo, K A

    • What is the significance of macrosomia? Diabetes Care July 1999 22:1201-1205; doi:10.2337/diacare.22.7.1201

  3. Thon, A

    • Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care July 1999 22:1151-1157; doi:10.2337/diacare.22.7.1151

  4. Toft-Nielsen, M B

    • Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Diabetes Care July 1999 22:1137-1143; doi:10.2337/diacare.22.7.1137

  5. Toki, Y

    • Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level. Diabetes Care July 1999 22:1220-1221; doi:10.2337/diacare.22.7.1220a

  6. Tominaga, Y

    • Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke. Diabetes Care July 1999 22:1191-1195; doi:10.2337/diacare.22.7.1191

  7. Torella, R

    • Aminotransferase activity and acarbose treatment in patients with type 2 diabetes. Diabetes Care July 1999 22:1217-1218; doi:10.2337/diacare.22.7.1217

  8. Torjesen, P A

    • Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care July 1999 22:1186-1190; doi:10.2337/diacare.22.7.1186

  9. Tritschler, H

    • alpha-Tocopherol induces leptin expression in healthy individuals and in vitro. Diabetes Care July 1999 22:1227-1228; doi:10.2337/diacare.22.7.1227a

  10. Tsai, J H

    • Increased urinary atrial natriuretic peptide-like immunoreactivity excretion but decreased plasma atrial natriuretic peptide concentration in patients with hyperosmolar-hyperglycemic nonketotic syndrome. Diabetes Care July 1999 22:1181-1185; doi:10.2337/diacare.22.7.1181

  11. Tsui, E Y

    • Cultural adaptation of the diabetes quality-of-life measure for Chinese patients. Diabetes Care July 1999 22:1216-1217; doi:10.2337/diacare.22.7.1216

  12. Tumini, S

    • Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Diabetes Care July 1999 22:1158-1164; doi:10.2337/diacare.22.7.1158

  13. Tuomilehto, J

    • The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care July 1999 22:1066-1070; doi:10.2337/diacare.22.7.1066

  14. Tuominen, J T

    • Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care July 1999 22:1196-1200; doi:10.2337/diacare.22.7.1196

  15. Turco, S

    • Aminotransferase activity and acarbose treatment in patients with type 2 diabetes. Diabetes Care July 1999 22:1217-1218; doi:10.2337/diacare.22.7.1217

U

  1. Uchimura, K

    • Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes. Diabetes Care July 1999 22:1221-1224; doi:10.2337/diacare.22.7.1221

  2. Ueki, Y

    • Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke. Diabetes Care July 1999 22:1191-1195; doi:10.2337/diacare.22.7.1191

V

  1. Vanelli, M

    • Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Diabetes Care July 1999 22:1158-1164; doi:10.2337/diacare.22.7.1158

  2. Verbeek, A L

    • Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy. Diabetes Care July 1999 22:1048-1052; doi:10.2337/diacare.22.7.1048

  3. Verhage, B

    • Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy. Diabetes Care July 1999 22:1048-1052; doi:10.2337/diacare.22.7.1048

  4. Verrotti, A

    • Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Diabetes Care July 1999 22:1158-1164; doi:10.2337/diacare.22.7.1158

  5. Vervoort, G

    • Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy. Diabetes Care July 1999 22:1048-1052; doi:10.2337/diacare.22.7.1048

  6. Vølund, A

    • Previous maternal abortion, longer gestation, and younger maternal age decrease the risk of type 1 diabetes among male offspring. Diabetes Care July 1999 22:1063-1065; doi:10.2337/diacare.22.7.1063

W

  1. Weinger, K

    • Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care July 1999 22:1022-1028; doi:10.2337/diacare.22.7.1022

  2. Wetzels, J F

    • Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy. Diabetes Care July 1999 22:1048-1052; doi:10.2337/diacare.22.7.1048

  3. Whitecotton, L

    • Work disability and diabetes. Diabetes Care July 1999 22:1105-1109; doi:10.2337/diacare.22.7.1105

  4. Willems, H

    • Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy. Diabetes Care July 1999 22:1048-1052; doi:10.2337/diacare.22.7.1048

  5. Williams, K V

    • Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study. Diabetes Care July 1999 22:1084-1091; doi:10.2337/diacare.22.7.1084

  6. Wolkotte, C

    • Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy. Diabetes Care July 1999 22:1048-1052; doi:10.2337/diacare.22.7.1048

Y

  1. Yano, M

    • Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke. Diabetes Care July 1999 22:1191-1195; doi:10.2337/diacare.22.7.1191

  2. Yoshino, G

    • Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes. Diabetes Care July 1999 22:1176-1180; doi:10.2337/diacare.22.7.1176

Z

  1. Zawacki, C M

    • Is pregnancy in diabetic women associated with folate deficiency? Diabetes Care July 1999 22:1017-1021; doi:10.2337/diacare.22.7.1017

  2. Ziegler, R

    • alpha-Tocopherol induces leptin expression in healthy individuals and in vitro. Diabetes Care July 1999 22:1227-1228; doi:10.2337/diacare.22.7.1227a

  3. Zimmet, P

    • Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study. Diabetes Care July 1999 22:1092-1096; doi:10.2337/diacare.22.7.1092

  4. Zinman, B

    • Cultural adaptation of the diabetes quality-of-life measure for Chinese patients. Diabetes Care July 1999 22:1216-1217; doi:10.2337/diacare.22.7.1216

Current Issue

  1. December 2009, 32 (12)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care